Aptose Biosciences Inc (APS) — Cash Flow-to-Debt Ratio
Aptose Biosciences Inc (APS) has a Cash Flow-to-Debt Ratio of -0.29x as of September 2025, meaning its operating cash flow of CA$-7.41 Million could theoretically repay 0% of its total liabilities (CA$25.79 Million) in one year. Check APS total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Aptose Biosciences Inc Cash Flow-to-Debt Ratio (1996–2024)
Historical debt coverage capacity for Aptose Biosciences Inc across 29 annual periods. Also explore how large is Aptose Biosciences Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Aptose Biosciences Inc (1996–2024)
Year-by-year debt coverage analysis for Aptose Biosciences Inc. For market capitalisation and broader financial context, see Aptose Biosciences Inc (APS) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.45x | CA$-35.98 Million | CA$14.67 Million | ▲ +12.6% |
| 2023 | -2.81x | CA$-44.59 Million | CA$15.89 Million | ▼ -15.3% |
| 2022 | -2.43x | CA$-32.32 Million | CA$13.29 Million | ▲ +53.4% |
| 2021 | -5.22x | CA$-43.30 Million | CA$8.29 Million | ▼ -13.3% |
| 2020 | -4.61x | CA$-33.89 Million | CA$7.35 Million | ▼ -40.2% |
| 2019 | -3.29x | CA$-21.56 Million | CA$6.55 Million | ▲ +60.4% |
| 2018 | -8.32x | CA$-23.21 Million | CA$2.79 Million | ▼ -43.7% |
| 2017 | -5.79x | CA$-10.22 Million | CA$1.76 Million | ▲ +37.3% |
| 2016 | -9.24x | CA$-12.17 Million | CA$1.32 Million | ▼ -59.0% |
| 2015 | -5.81x | CA$-9.89 Million | CA$1.70 Million | ▼ -17.5% |
| 2014 | -4.95x | CA$-9.94 Million | CA$2.01 Million | ▼ -76.5% |
| 2013 | -2.80x | CA$-4.94 Million | CA$1.76 Million | ▼ -127.0% |
| 2012 | -1.23x | CA$-3.21 Million | CA$2.60 Million | ▲ +75.7% |
| 2011 | -5.09x | CA$-6.03 Million | CA$1.19 Million | ▼ -288.8% |
| 2010 | -1.31x | CA$-3.53 Million | CA$2.70 Million | ▼ -187.9% |
| 2009 | -0.45x | CA$-6.62 Million | CA$14.57 Million | ▲ +31.1% |
| 2008 | -0.66x | CA$-10.25 Million | CA$15.55 Million | ▼ -54.2% |
| 2007 | -0.43x | CA$-5.88 Million | CA$13.76 Million | ▲ +54.1% |
| 2006 | -0.93x | CA$-11.87 Million | CA$12.73 Million | ▲ +28.8% |
| 2005 | -1.31x | CA$-14.92 Million | CA$11.40 Million | ▲ +0.0% |
| 2004 | -1.31x | CA$-14.92 Million | CA$11.40 Million | ▲ +72.8% |
| 2003 | -4.82x | CA$-20.60 Million | CA$4.28 Million | ▼ -38.8% |
| 2002 | -3.47x | CA$-7.79 Million | CA$2.25 Million | ▲ +0.0% |
| 2001 | -3.47x | CA$-7.79 Million | CA$2.25 Million | ▼ -110.6% |
| 2000 | -1.65x | CA$-6.28 Million | CA$3.81 Million | ▼ -10.9% |
| 1999 | -1.49x | CA$-3.58 Million | CA$2.41 Million | ▲ +46.3% |
| 1998 | -2.77x | CA$-2.44 Million | CA$881.66K | ▲ +30.8% |
| 1997 | -4.00x | CA$-3.02 Million | CA$755.18K | ▼ -22.2% |
| 1996 | -3.27x | CA$-2.61 Million | CA$798.14K | — |